Skip to content
OpenCapital
Get started

ICU Medical ICUI Accrued liability Italy payment scheme

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%
Free cash flow$27.6M-24.8%

Valuation

See full
Market cap$3.39B-6.3%

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept icui:AccruedLiabilityItalyPaymentScheme.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is ICU Medical's accrued liability italy payment scheme?
ICU Medical (ICUI) reported accrued liability italy payment scheme of $25.08M in Q1 2026.
How has ICU Medical's accrued liability italy payment scheme changed year-over-year?
ICU Medical's accrued liability italy payment scheme decreased by 1.8% year-over-year, from $25.53M to $25.08M.
What is the long-term trend for ICU Medical's accrued liability italy payment scheme?
Over 3 years (2022 to 2025), ICU Medical's accrued liability italy payment scheme has grown at a 46.0% compound annual growth rate (CAGR), from $7.9M to $24.6M.